Design, expression, purification, and application of novel recombinant miR-491 molecules to define the biogenesis and function of miR-491-3p versus -5p in posttranscriptional regulation of UDP-glucuronosyltransferase 1A1
Open Access
- 4 April 2026
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 54 (5) , 100292
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences (R35GM140835)
- National Cancer Institute (R01CA291771)
- National Cancer Institute (P30CA093373)
- National Institutes of Health
- University of California, Davis
This publication has 64 references indexed in Scilit:
- Kinetic Characterization of Estradiol Glucuronidation by Liver Microsomes and Expressed UGT Enzymes: The Effects of Organic SolventsEuropean Journal of Drug Metabolism and Pharmacokinetics, 2024
- Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancerActa Pharmaceutica Sinica B, 2023
- Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivoActa Pharmaceutica Sinica B, 2021
- Expression and Purification of tRNA/pre-miRNA-Based Recombinant Noncoding RNAs2021
- Recent progress and challenges in screening and characterization of UGT1A1 inhibitorsActa Pharmaceutica Sinica B, 2019
- Transcriptome association analysis identifies miR-375 as a major determinant of variable acetaminophen glucuronidation by human liverBiochemical Pharmacology, 2016
- Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): Mechanisms responsible for interindividual variation of UGT levelsBiochemical Pharmacology, 2010
- The Guideline of the Design and Validation of MiRNA Mimics2010
- Functional screening identifies a microRNA, miR‐491 that induces apoptosis by targeting Bcl‐XL in colorectal cancer cellsInternational Journal of Cancer, 2010
- The interactions between the N-terminal and C-terminal domains of the human UDP-glucuronosyltransferases are partly isoform-specific, and may involve both monomersBiochemical Pharmacology, 2004